Sands Capital Management, LLC Biogen Inc. Transaction History

Sands Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $296 Million - $419 Million	-1,138,777 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $21 Million - $23.6 Million	-68,395 Reduced 5.67%	1,138,777 $363 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $20 Million - $23.4 Million	-70,991 Reduced 5.55%	1,207,172 $378 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,278,163	1,278,163 $347 Million

1,015

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sands Capital Management, LLC with notifications on news.